.svg)
One question has guided his path: how do you turn a technology born in a laboratory into a treatment clinicians use every day? He has answered it three times.
At Sorin Group, working on pacemakers with no leads and no battery. His doctoral thesis addressed precisely the energy harvesting that would make such implants self-sufficient.
At Pixium Vision, for eight years, leading the development of an artificial vision implant. The device reached clinical trials and allowed blind patients with AMD to regain functional vision.
At Theraclion since 2020, on HIFU echotherapy applied to varicose veins.
His ambition has been the same at every stage: reach hundreds of patients first, then hundreds of thousands, while building a company that lasts.
He signs: the technology behind HIFU echotherapy, how the Sonovein® device works, its regulatory status, and Theraclion's industrial trajectory.
He does not sign: medical advice, diagnosis or treatment indications. Clinical content on this blog is reviewed and signed by a physician.
| Years | Institution | Degree | Location |
|---|---|---|---|
| 2010 to 2013 | Paris-Sud University, Institut d'Électronique Fondamentale | PhD in physics | Orsay, France |
| — | Massachusetts Institute of Technology | Master's degree | Cambridge, United States |
| Class of 2005 | École polytechnique | Master's degree | Palaiseau, France |
Thesis: Toward an Energy Harvester for Leadless Pacemakers, defended in 2013.
| Years | Role | Company |
|---|---|---|
| Since May 2023 | Chief Executive Officer | Theraclion |
| 2020 to 2023 | Head of engineering | Theraclion |
| 8 years | Head of development, artificial vision implant | Pixium Vision |
| — | Research and development, leadless batteryless pacemakers | Sorin Group |
